Oncology diagnostics firm Oncocyte Corp. announced Tuesday a rebranding and relocation of the company’s headquarters from ...

Itasca (IL), United States - June 17, 2025. Biocartis Group of Companies (“Biocartis”), an innovative precision oncology company, is pleased to announce the appointment of Ben Svarczkopf, MS, MT (ASCP ...

KFDA approval is a pivotal milestone for UltraSight™ as we expand access to critical cardiac imaging tools in one of Asia’s most innovative healthcare markets.” — Davidi Vortman, CEO of UltraSight™ ...

This program covers multiple aspects of a successful farmers market for both market managers and market vendors. Content includes market regulations, food safety, liability, sustaining a stable market ...

Compared to its diagnostic predecessors, LUCAS creates 500-fold stronger and 8-fold longer-lasting bioluminescence signals, overcoming longstanding challenges faced by point-of-care diagnostics.

A research team funded by the National Institutes of Health (NIH) has identified a diagnostic aid that has the potential to accurately predict the recurrence of diabetic foot ulcers that appear to ...

The Malvern location of Fujirebio Diagnostics Inc.’s played a key role in the clinical development of the first FDA-approved blood test that can help diagnose Alzheimer’s disease. The test, cleared ...

M.D., Chief Medical Officer of Foresight Diagnostics. "This study adds to a growing body of clinical evidence that we believe should strengthen the field's confidence in our assay's ability to ...

Identifying the best measures and defining the level of effectiveness required for each measure is a highly complex task. The CASES Diagnostic supports you in this process.